4//SEC Filing
Novack David F 4
Accession 0001029142-25-000061
CIK 0001029142other
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 9:44 PM ET
Size
5.1 KB
Accession
0001029142-25-000061
Insider Transaction Report
Form 4
Novack David F
President & COO
Transactions
- Sale
Common Stock
2025-03-07$14.39/sh−32,764$471,474→ 22,098 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 6, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $14.22 to $14.61; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.
Documents
Issuer
DYNAVAX TECHNOLOGIES CORP
CIK 0001029142
Entity typeother
Related Parties
1- filerCIK 0001573072
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 9:44 PM ET
- Size
- 5.1 KB